These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: One-month injectables are popular choice in Mexico.
    Journal: Netw Res Triangle Park N C; 1984; 5(3):4-5. PubMed ID: 12279798.
    Abstract:
    In Latin America over 100,000 women use monthly injectable contraceptives. These injectables are not part of any national program and are manufactured by local companies. Convenience and secretiveness were 2 primary reasons given by a group of injectable contraceptive users for preferring this method to all other forms of birth control. This was 1 of the findings of a study undertaken by Promotora de Planificacion Familiar A.C. (PROFAM) in Mexico to assess the market for a 1 month injectable, to include in its contraceptive social marketing program. In depth information was obtained about the attitudes and perceptions of present users of injectables with regard to the advantages of the method compared to other contraceptives and the motivation to use the 1 month rather than the 3 month product. In December 1983 PROFAM conducted a motivational study of injectable contraceptive users, utilizing 4 discussion groups composed of women who used 1 month injectables and were residents of several randomly selected lower middle income and low income areas of metropolitan Mexico City. The older women in the study had generally begun to use injectables after other methods were deemed unsatisfactory. They had either had physical or psychological complaints about their previous methods or were worried about effectiveness. Injectables were considered by all the women to be "less troublesome" than but as effective as either oral contraceptives (OCs) or the IUD. Features most often cited in favor of injectables were their effectiveness, lack of rumors about side effects, the possibility of secrecy, and ease of correct use. Knowledge about injectables was widespread, and the women reported no difficulty in getting the information they wanted from friends, drugstore personnel, or doctors. The product usually reached the consumer without a medical prescription. Finding someone to administer the shot was the principal drawback of an injectable contraceptive. Middle class women usually found that small, private clinics provided the service for a moderate fee. Those women who had had continuous difficulties getting an injection had finally resorted to heighborhood acquaintances or else had learned the technique themselves. The women in the study stated a definite preference for injectables in the 1 month rather than the 3 month form, indicating that remembering the date of the last shot over a 3 month period would be too difficult. No advantages could be seen in 3 month injectables, and they would be passed up in favor of the 1 month product. The study concluded that PROFAM should include a low cost, high quality monthly injectable among its contraceptive products.
    [Abstract] [Full Text] [Related] [New Search]